NDC 0713-0897 – Vyleesi

Bremelanotide Acetate 1.75 mg/.3mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC0713-0897

Product details

Brand name
Vyleesi
Generic name
Bremelanotide
Labeler
Cosette Pharmaceuticals, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
NDA · NDA210557
Marketed since
November 12, 2025
Listing expires
December 31, 2026
Pharmacologic class
Melanocortin Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Vyleesi →

Package NDC codes (1)

Package NDCDescriptionSince
0713-0897-044 SYRINGE in 1 CARTON (0713-0897-04) / .3 mL in 1 SYRINGE (0713-0897-06)Nov 12, 2025